Cantwell, R, Harrison, G.
Substance misuse in the severely mentally ill. Adv Psychiatr Treat
1996; 2: 117–24.
Hunt, GE, Bergen, J, Bashir, M.
Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophr Res
2002; 54: 253–64.
Appleby, L, Shaw, J, Amos, T, McDonnell, R, Harris, C, McCann, K, et al. Suicide within 12 months of contact with mental health services: national clinical survey. BMJ
1999; 318: 1235–9.
Stewart, D, Gossop, M, Marsden, J, Alexander, JM. Drug misuse and acquisitive crime among clients recruited to the National Treatment Outcome Research Study (NTORS). Crim Behav Ment Health
2002; 10: 10–20.
Sinha, R, Easton, C.
Substance abuse and criminality. J Am Acad Psychiatry Law
1999; 27: 513–26.
Phillips, P, Johnson, S.
Drug and alcohol misuse among in-patients with psychotic illnesses in three inner-London psychiatric units. Psychiatr Bull
2003; 27: 217–20.
George, S, Braithwaite, RA. Use of on-site testing for drugs of abuse. Clin Chem
2002; 48: 1639–46.
Jenkins, AJ, Goldberger, BA. On-Site Drug Testing. Humana Press, 2002.
Kranzler, HR, Stone, J, McLaughlin, L.
Evaluation of a point-of-care testing product for drugs of abuse; testing site is a key variable. Drug Alcohol Depend
1995; 40: 55–62.
Wolff, K, Welch, S, Strang, J.
Specific laboratory investigations for assessments and management of drug problems. Adv Psychiatr Treat
1999; 5: 180–91.
Biological markers of drug use. Psychiatry
2006; 5: 439–41.
Wu, AHB, Forte, E, Casella, G, Sun, K, Hemphill, G, Foery, R, et al. CEDIA for screening drugs-of-abuse in urine and the effect of adulterants. J Forensic Sci
1995; 40: 614–8.
National Academy of Clinical Biochemistry. Evidence-based practice for point of care testing. In Drugs and Ethanol: 63–75. AACC Press, 2006.